About ADHD
What is ADHD?
Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition marked by patterns of inattention, hyperactivity, and impulsivity that are not typical for a person’s age. It affects approximately 5% of children and adolescents-more often boys-and around 2.5% of adults, according to the World Health Organization. ADHD can interfere with academic performance, family life, and social relationships, often persisting from early childhood into adulthood.
When ADHD Appears and Related Conditions
Symptoms often start before school age, with many children showing signs as early as 2.5 years. Beyond its core traits, ADHD is frequently linked with other challenges such as sleep problems, mood disorders, oppositional behaviors, and even physical issues like obesity. These co-occurring conditions can make day-to-day functioning even harder, further affecting relationships, learning, and self-esteem.
Importance of Early Diagnosis
Detecting ADHD early- especially in children under 5- can greatly improve outcomes. Early interventions can help children develop vital skills in emotional regulation, attention control, and social interaction. This proactive approach reduces the long-term impact on school performance and personal relationships, giving children a stronger foundation for success later in life.
Treatment Approaches
Experts recommend a multimodal treatment strategy combining non-medication and medication-based interventions. Behavioral therapy is the first-line treatment for children under 6, while older children and adults may benefit from a combination of behavioral strategies and medications. Common medications include stimulants like methylphenidate and amphetamines, as well as non-stimulants such as atomoxetine, guanfacine, and clonidine. The goal is to address symptoms using a holistic approach for the best possible results.
NCMH - Cardiff University YouTube video
* This information is not meant to diagnose or treat and should not take the place of personal consultation, as appropriate, with a qualified healthcare professional
References: 1. American Psychiatric Association (APA) (2022). Diagnostic and statistical manual of mental disorders (5th edn, text rev.). Washington, DC: American Psychiatric Association); 2. Yüksel, A., N. DoÄŸan, A. TahıllıoÄŸlu, O. Bilaç, T. Uysal and E. Ercan (2023). "ADHD and its associations with pregnancy, birth, developmental and medical-related characteristics." Current Psychology 42: 4705–4718.; 3. Rattay, K. and L. R. Robinson (2024). "Identifying Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD): a Public Health Concern and Opportunity." Prev Sci 25(Suppl 2): 195-202.; 4. Faraone, S.V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M.A., ... & Wang, Y. (2021). The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews, 128, 789–818); 5. Dalrymple, R. A., L. McKenna Maxwell, S. Russell and J. Duthie (2020). "NICE guideline review: Attention deficit hyperactivity disorder: diagnosis and management (NG87)." Arch Dis Child Educ Pract Ed 105(5): 289-293.; 6. Cortese S, Song M, Farhat LC, et al. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the global burden of disease study. Mol Psychiatry. 2023;28(11):4823–4830; 7. Brites, C., H. D. Brites, R. P. de Almeida, G. D. Gotardo Mata and L. M. Dias Brites (2023). "Early Diagnosis on ADHD: Is It Possible?" Psychology 14: 359-370.; 8. Kian, N., N. Samieefar and N. Rezaei (2022). "Prenatal risk factors and genetic causes of ADHD in children." World J Pediatr 18(5): 308-319; 9. Sibley MH, Bruton AM, Zhao X, Johnstone JM, Mitchell J, Hatsu I, Arnold LE, Basu HH, Levy L, Vyas P, Macphee F, Gonzalez ES, Kelley M, Jusko ML, Bolden CR, Zulauf-McCurdy C, Manzano M, Torres G. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health. 2023 Jun;7(6):415-428); 10. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. 2022 Feb;230:107940).